MK-1045 (CN201)

· MSD R&D (China) Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MK-1045 (CN201), covering 2026-02-13 to 2026-03-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate MK-1045 (CN201) in Participants With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (MK-1045-001/CN201-101) [Phase 1]

See pricing